Deutsche Bank re-initiated coverage of Johnson Matthey with a Buy rating and 2,400 GBp price target. The analyst believes Johnson Matthey has underappreciated strategic value in its catalyst and hydrogen businesses.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JMPLY:
- Johnson Matthey price target raised to 1,950 GBp from 1,650 GBp at UBS
- Johnson Matthey price target raised to 2,170 GBp from 2,030 GBp at Barclays
- Johnson Matthey signs definitive agreement to sell its MDC business to Montagu
- Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m